Looks very interesting here, but read the 10Q...... there seems to be a fair bit of dilution baked in as they issued a ton of stock to pay off debt, and i think they have warrents or other committment that requires stock to be issued. thats why i think the stock got slammed.
i am a long, but the Morgan Stanley question on the CC said it all. We have no sales or purchase orders for either drug. It was supposed to launch in q3 but did not.......... its the single biggest problem and its not clear if they can really pull it off. and its the main reason why 10M shares are sitting on a short.
I have owned rmti for serveral years, the massive short position at some point has to close out to make any real money. I have traded options on it for a long time successfully, and still own the stock - that is finally starting the execute the NEW revenue and products.... Now is not the time to sell as they are just starting to go to market.
This is not to say the stock will only move up, its way over manipulated for that. If it runs up too fast, i just sell come covered calls. If we really start to see the short positions close out completely, then we might see stable higher prices in the stock.
All good, except... that they have been totally unable to operate profitably even with the current massive contacts and orders. why will more govt. contracts change that metric? seems like they need to operate are change price structure or something... as there are no profits in sight???
remember the 18%shareholders in merger took all there stock at 4.50$/sh back in March 2015. Ouch. So now ANOTHER secondary is issued at $1.57 (one year after the previous issue ance)
Not a happy shareholder, will watch to see if they can pull some surprises but so far they are not making it worth the wait at this point.